BDBM573966 2-amino-9-[(2R,5S,7R,8R,10R, 12aR,14R,15aS)-14-(4-aminoimidazo[2,1- f][1,2,4]triazin-7-yl)-2,10-dioxido-2,10- disulfanyloctahydro-12H-5,8-methanofuro[3,2- l][1,3,6,9,11,2,10] pentaoxadiphosphacyclotetradecin-7-yl]-1,9- dihydro-6H-purin-6-one (Diastereomer 3)::US11453697, Example 151

SMILES Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H]2C[C@H]1O[P@@](S)(=O)OC[C@H]1O[C@H](C[C@@H]1O[P@@](S)(=O)OC2)c1cnc2c(N)ncnn12

InChI Key InChIKey=CECDHZWLARQXCJ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 573966   

LigandPNGBDBM573966(US11453697, Example 151 | 2-amino-9-[(2R,5S,7R,8R,...)
Affinity DataEC50: <1nMAssay Description:The compounds were serially titrated by the Hamilton STARPlus CORE in a 96-well plate (Greiner, #651201) using a 1:3 ten-point dose response format. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent